Georgetown University Medical Center licenses 'theranostic' for development
Tuesday, January 24, 2012 - 11:01
in Health & Medicine
Georgetown University Medical Center (GUMC) has licensed worldwide rights of a potential novel cancer therapy and diagnostic, or "theranostic," to BioMetrx, LLC. The agent was invented by two Georgetown researchers.